HC Wainwright assumes GNFT, VALN
StreetAccount Sector Summary - Healthcare Post-Market
FDA grants orphan drug designation to elafibranor for primary sclerosing cholangitis (PSC) (€105.70, 0.00)
StreetAccount Summary - Trading higher/lower: EU mid-morning
StreetAccount Summary - European pre-market trading update
GENFIT reports Q1 revenue €2.8M vs year-ago €1.1M (€4.05, 0.00)
GENFIT to receive €26.5M milestone payment following approval of pricing and reimbursement of Ipsen's Iqirvo in Italy (€3.84, 0.00)
StreetAccount Summary - US Pre-market trading update
Powered by FactSet Research Systems Inc.